Cetuximab plus triplet

ABSTRACT: Primary objectives: To investigate the rate of patients submitted to surgery for liver metastases after a triplet induction chemotherapy (CPT-11, 5-fluorouracil-leucovorin, oxaliplatin) plus Erbitux in patients with liver metastases from colorectal cancer Primary endpoints: Resection rate of liver metastases

DISEASE(S): Liver Metastases From Colorectal Cancer

PROVIDER: 2518979 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR